Clinical parameters affecting the therapeutic efficacy of empagliflozin in patients with type 2 diabetes

We aimed to investigate the clinical factors affecting the therapeutic effectiveness of the sodium–glucose cotransporter-2 inhibitor empagliflozin in patients with type 2 diabetes mellitus (T2DM). We reviewed the medical records of 374 T2DM patients aged between 20 and 75 years who were prescribed e...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Yun Kyung, Lee, Jiwoo, Kang, Yu Mi, Yoo, Jee Hee, Park, Joong-Yeol, Jung, Chang Hee, Lee, Woo Je
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675078/
https://www.ncbi.nlm.nih.gov/pubmed/31369642
http://dx.doi.org/10.1371/journal.pone.0220667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675078/
https://www.ncbi.nlm.nih.gov/pubmed/31369642
http://dx.doi.org/10.1371/journal.pone.0220667

Ejemplares similares